News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Chen Jing
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 07/28/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/09/2022 |
4
| Chen Jing (Director) has filed a Form 4 on Biostage, Inc.|
Txns:
| Sold 48,532 shares
@ $7.17, valued at
$348k
Exercised (in-or-at-the-money) 174,000 warrants
@ $2, valued at
$348k
|
|
| 07/01/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/10/2021 |
4
| Chen Jing (Director) has filed a Form 4 on Biostage, Inc.|
Txns:
| Granted 22,500 options to buy
@ $1.35, valued at
$30.4k
Granted 18,035 options to buy
@ $1.35, valued at
$24.3k
|
|
| 06/29/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/05/2019 |
4
| Chen Jing (Director) has filed a Form 4 on Biostage, Inc.|
Txns:
| Granted 10,364 options to buy
@ $2.9, valued at
$30.1k
Granted 8,411 options to buy
@ $2.9, valued at
$24.4k
Granted 7,554 options to buy
@ $2.9, valued at
$21.9k
|
|
| 11/15/2018 |
4
| Chen Jing (Director) has filed a Form 4 on Biostage, Inc.|
Txns:
| Granted 10,897 options to buy
@ $2.75, valued at
$30k
|
|
| 07/06/2018 |
4
| Chen Jing (Director) has filed a Form 4 on Biostage, Inc.|
Txns:
| Converted 27,000 shares
@ $0
Converted 54 convertible preferred
@ $2, valued at
$108 |
|
|
|